CAMBRIDGE, Mass. & TRIESTE, Italy--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ), a global leader in biotechnology, and the International Center for Genetic Engineering and Biotechnology (ICGEB), a not-for-profit research and development (R&D) organization, announced today a new research collaboration to advance treatments for neglected diseases. The collaboration between Genzyme and ICGEB will initially focus on the development of new, improved treatments for malaria, a debilitating infectious disease of developing countries.
